Vascular and endovascular surgery · 2008
Midterm follow-up after pharmacomechanical thrombolysis for lower extremity deep venous thrombosis.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Gasparis Antonios P, Labropoulos Nicos, Tassiopoulos Apostolos K, Phillips Brett, Pagan Jose, Cheng Lo, Ricotta John
Аннотация
OBJECTIVE: To provide follow-up in patients treated with pharmacomechanical thrombolysis (PhMT) for lower extremity deep venous thrombosis (DVT).
METHODS: Retrospective analysis of prospectively collected data. Patients underwent clinical evaluation, duplex ultrasound, venous clinical severity scoring, venous segmental disease scoring, and venous disability scoring.
RESULTS: Fourteen patients were available for evaluation. Median age was 40 years (19-58). Median follow-up was 24 months (13-69 months). Thirteen of 14 patients (93%) had a venous disability score < 1 and 13 of 14 patients (93%) had a venous clinical severity scoring < 5. In all but 1 patient the venous segmental disease scoring score was < 5. All iliac segments were patent, all but 3 patients had partial infrainguinal obstruction and 5 of 14 (36%) had reflux.
CONCLUSIONS: Our data demonstrate that the good early clinical results after PhMT can be sustained on longer follow-up and may prevent the development of advanced postthrombotic syndrome.
METHODS: Retrospective analysis of prospectively collected data. Patients underwent clinical evaluation, duplex ultrasound, venous clinical severity scoring, venous segmental disease scoring, and venous disability scoring.
RESULTS: Fourteen patients were available for evaluation. Median age was 40 years (19-58). Median follow-up was 24 months (13-69 months). Thirteen of 14 patients (93%) had a venous disability score < 1 and 13 of 14 patients (93%) had a venous clinical severity scoring < 5. In all but 1 patient the venous segmental disease scoring score was < 5. All iliac segments were patent, all but 3 patients had partial infrainguinal obstruction and 5 of 14 (36%) had reflux.
CONCLUSIONS: Our data demonstrate that the good early clinical results after PhMT can be sustained on longer follow-up and may prevent the development of advanced postthrombotic syndrome.
Предметные рубрики MeSH
AdultAgedAnticoagulantsCombined Modality TherapyDisability EvaluationFemaleHumansLower ExtremityMaleMiddle AgedPhlebographyPostthrombotic SyndromeRetrospective StudiesSeverity of Illness IndexThrombectomyThrombolytic TherapyTime FactorsTreatment OutcomeUltrasonography, Doppler, ColorVascular PatencyVenous ThrombosisYoung Adult